MethCORR modelling of methylomes from formalin-fixed paraffin-embedded tissue enables characterization and prognostication of colorectal cancer.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 04 2020
Historique:
received: 03 03 2019
accepted: 02 04 2020
entrez: 26 4 2020
pubmed: 26 4 2020
medline: 11 8 2020
Statut: epublish

Résumé

Transcriptional characterization and classification has potential to resolve the inter-tumor heterogeneity of colorectal cancer and improve patient management. Yet, robust transcriptional profiling is difficult using formalin-fixed, paraffin-embedded (FFPE) samples, which complicates testing in clinical and archival material. We present MethCORR, an approach that allows uniform molecular characterization and classification of fresh-frozen and FFPE samples. MethCORR identifies genome-wide correlations between RNA expression and DNA methylation in fresh-frozen samples. This information is used to infer gene expression information in FFPE samples from their methylation profiles. MethCORR is here applied to methylation profiles from 877 fresh-frozen/FFPE samples and comparative analysis identifies the same two subtypes in four independent cohorts. Furthermore, subtype-specific prognostic biomarkers that better predicts relapse-free survival (HR = 2.66, 95%CI [1.67-4.22], P value < 0.001 (log-rank test)) than UICC tumor, node, metastasis (TNM) staging and microsatellite instability status are identified and validated using DNA methylation-specific PCR. The MethCORR approach is general, and may be similarly successful for other cancer types.

Identifiants

pubmed: 32332866
doi: 10.1038/s41467-020-16000-6
pii: 10.1038/s41467-020-16000-6
pmc: PMC7181739
doi:

Substances chimiques

Biomarkers, Tumor 0
Formaldehyde 1HG84L3525

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2025

Subventions

Organisme : NCI NIH HHS
ID : R01 CA207467
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

JCO Precis Oncol. 2018;2018:
pubmed: 29862382
Sci Rep. 2018 Mar 26;8(1):5190
pubmed: 29581450
Lab Invest. 2013 Jun;93(6):701-10
pubmed: 23568031
Trends Genet. 2013 Oct;29(10):569-74
pubmed: 23810203
Cancers (Basel). 2013 Jan 31;5(1):149-69
pubmed: 24216702
BMC Cancer. 2011 Dec 30;11:529
pubmed: 22208948
Mol Oncol. 2017 Nov;11(11):1544-1560
pubmed: 28796930
Semin Cancer Biol. 2019 Apr;55:37-52
pubmed: 29775690
Clin Epidemiol. 2016 Jan 28;8:15-21
pubmed: 26869813
Sci Rep. 2019 May 6;9(1):6980
pubmed: 31061401
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Int J Genomics. 2017;2017:1926304
pubmed: 28246590
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
BMC Genomics. 2014 Dec 11;15:1087
pubmed: 25495041
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Arch Pathol Lab Med. 2010 Jun;134(6):837-52
pubmed: 20524862
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4164-9
pubmed: 15016911
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
J Clin Oncol. 2011 Jan 1;29(1):17-24
pubmed: 21098318
Nature. 2015 Sep 10;525(7568):251-5
pubmed: 26287467
PeerJ. 2019 May 01;7:e6757
pubmed: 31106051
Front Immunol. 2012 Sep 12;3:283
pubmed: 22988448
Toxicol Appl Pharmacol. 2017 Sep 15;331:6-17
pubmed: 28336213
PLoS One. 2017 Jan 25;12(1):e0170632
pubmed: 28122052
Pathol Int. 2018 Nov;68(11):633-635
pubmed: 30239063
Nat Genet. 2006 May;38(5):500-1
pubmed: 16642009
PLoS Curr. 2010 Sep 02;2:
pubmed: 20877447
Nat Genet. 2012 Nov;44(11):1236-42
pubmed: 23064414
Epigenomics. 2016 Mar;8(3):389-99
pubmed: 26673039
Genome Biol. 2014 Feb 20;15(2):R37
pubmed: 24555846
PLoS One. 2010 Nov 15;5(11):e13984
pubmed: 21085593
Cell Rep. 2017 May 9;19(6):1268-1280
pubmed: 28494874
Lab Invest. 2015 Jul;95(7):833-42
pubmed: 25867767
Oncotarget. 2015 Oct 13;6(31):31674-92
pubmed: 26397224
PLoS One. 2014 May 30;9(5):e98187
pubmed: 24878701
BMC Bioinformatics. 2010 Jul 02;11:367
pubmed: 20598126
Nucleic Acids Res. 2015 Jan;43(Database issue):D1113-6
pubmed: 25361974
PLoS One. 2017 Jul 25;12(7):e0181756
pubmed: 28742856
Genome Biol. 2014 Feb 03;15(2):R30
pubmed: 24490765
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
Nat Commun. 2017 May 31;8:15107
pubmed: 28561063
BMC Bioinformatics. 2013 Dec 12;14:359
pubmed: 24330312
Nat Commun. 2019 Aug 23;10(1):3834
pubmed: 31444360
Virchows Arch. 2018 Oct;473(4):405-412
pubmed: 30030621
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Science. 2017 Feb 17;355(6326):752-756
pubmed: 28209900
Bioinformatics. 2014 Feb 01;30(3):428-30
pubmed: 24336642
PLoS One. 2019 May 6;14(5):e0216050
pubmed: 31059554
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nucleic Acids Res. 2011 May;39(9):e63
pubmed: 21317187
Cell Rep. 2018 Jun 12;23(11):3407-3418
pubmed: 29898408
Oncotarget. 2016 Dec 6;7(49):81778-81790
pubmed: 27835889
PLoS One. 2007 Nov 21;2(11):e1195
pubmed: 18030330
Nat Genet. 2015 Apr;47(4):312-9
pubmed: 25706627
Gut. 2012 Nov;61(11):1560-7
pubmed: 22213796
BMC Biol. 2014 May 30;12:42
pubmed: 24885439
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Epigenetics. 2014 Jun;9(6):829-33
pubmed: 24732293
Nat Genet. 2015 Sep;47(9):1091-8
pubmed: 26258848
Clin Epigenetics. 2015 Sep 17;7:101
pubmed: 26388956
Nat Rev Cancer. 2009 Apr;9(4):265-73
pubmed: 19262571
Nat Commun. 2013;4:2612
pubmed: 24113773
Genome Biol. 2013;14(10):R115
pubmed: 24138928
Genome Biol. 2014 Apr 01;15(4):r54
pubmed: 24690455
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11026-31
pubmed: 20534479
Pac Symp Biocomput. 2016;22:509-520
pubmed: 27897002
PLoS One. 2013 Nov 22;8(11):e81925
pubmed: 24278466
Gastroenterology. 2010 Jun;138(6):2088-100
pubmed: 20420948
PLoS Biol. 2004 Aug;2(8):E239
pubmed: 15269788
Sci Rep. 2015 Jul 23;5:12335
pubmed: 26202458

Auteurs

Trine B Mattesen (TB)

Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus, Denmark.

Mads H Rasmussen (MH)

Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus, Denmark.

Juan Sandoval (J)

Epigenomic Unit, Health Research Institute La Fe (ISSLaFe), Valencia, Spain.
Biomarker and precision medicine Unit, Health Research Institute La Fe (ISSLaFe), Valencia, Spain.

Halit Ongen (H)

Genetic Medicine and Development, University of Geneva Medical School-CMU, 1 Rue Michel-Servet, 1211, Geneva, Switzerland.

Sigrid S Árnadóttir (SS)

Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus, Denmark.

Josephine Gladov (J)

Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus, Denmark.

Anna Martinez-Cardus (A)

Badalona Applied Research Group in Oncology (B-ARGO), Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelona, Catalonia, Spain.
Medical Oncology Service, Institute Catalan of Oncology (ICO), Badalona, Barcelona, Catalonia, Spain.

Manuel Castro de Moura (M)

Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.

Anders H Madsen (AH)

Department of Surgery, Hospitalsenheden Vest, 7400, Herning, Denmark.

Søren Laurberg (S)

Colorectal Surgical Unit, Department of Surgery, Aarhus University Hospital, 8200, Aarhus, Denmark.

Emmanouil T Dermitzakis (ET)

Genetic Medicine and Development, University of Geneva Medical School-CMU, 1 Rue Michel-Servet, 1211, Geneva, Switzerland.

Manel Esteller (M)

Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.
Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.
Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Catalonia, Spain.

Claus L Andersen (CL)

Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus, Denmark. Cla@clin.au.dk.

Jesper B Bramsen (JB)

Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus, Denmark. Bramsen@clin.au.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH